Vision-Related Quality of Life and Treatment Satisfaction Following Panretinal Photocoagulation in Diabetic Retinopathy—A Panel Study
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design and Population
2.1.1. Phase 1: Data Collection
2.1.2. Phase 2: Procedures
2.1.3. Phase 3: Study Instruments
2.2. Statistical Analysis
3. Results
3.1. Characteristics of the Participants
3.2. BCVA, CMT and Visual Field Changes
3.3. Quality of Life and Treatment Satisfaction Assessment
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Appendix A
Appendix B
References
- Resnikoff, S.; Pascolini, D.; Etya’ale, D.; Kocur, I.; Pararajasegaram, R.; Pokharel, G.P.; Mariotti, S.P. Global data on visual impairment in the year 2002. Bull. World Health Organ. 2004, 82, 844–851. [Google Scholar]
- Brose, L.S.; Bradley, C. Psychometric development of the retinopathy treatment satisfaction questionnaire (RetTSQ). Psychol. Health Med. 2009, 14, 740–754. [Google Scholar] [CrossRef]
- Wong, T.; Klein, K. The epidemiology of eye diseases in diabetes. In The Epidemiology of Diabetes Mellitus, 2nd ed.; Ekoe’, J., Rewers, M., Williams, R., Zimmet, P., Eds.; John Wiley & Sons: Oxford, UK, 2008; pp. 475–497. [Google Scholar]
- The Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. Ophthalmology 1981, 88, 583–600. [Google Scholar]
- Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS Report Number 9. Ophthalmology 1991, 98, 766–785. [Google Scholar] [CrossRef]
- Fong, D.S.; Girach, A.; Boney, A. Visual side effects of successful scatter laser photocoagulation surgery for proliferative diabetic retinopathy: A literature review. Retina 2007, 27, 816–824. [Google Scholar] [CrossRef]
- Shimura, M.; Yasuda, K.; Nakazawa, T.; Tamai, M. Visual dysfunction after panretinal hotocoagulation in patients with severe diabetic retinopathy and good vision. Am. J. Ophthalmol. 2005, 140, 8–15. [Google Scholar] [CrossRef]
- Bek, T.; Erlandsen, M. Visual prognosis after panretinal photo-coagulation for proliferative diabetic retinopathy. Acta Ophthalmol. Scand. 2006, 84, 16–20. [Google Scholar] [CrossRef] [PubMed]
- Tranos, P.G.; Topouzis, F.; Stangos, N.T.; Dimitrakos, S.; Economidis, P.; Harris, M.; Coleman, A.L. Effect of laser photocoagulation treatment for diabetic macular oedema on patient’s vision-related quality of life. Curr. Eye Res. 2004, 29, 41–49. [Google Scholar] [CrossRef]
- Speight, J.; Reaney, M.D.; Barnard, K.D. Not all roads lead to Rome-a review of quality of life measurement in adults with diabetes. Diabet. Med. 2009, 26, 315–327. [Google Scholar] [CrossRef] [PubMed]
- Woodcock, A.; Plowright, R.; Kennedy-Martin, T.; Hirsch, A.; Ffytche, T.; Bradley, C. Development of the new Retinopathy Treatment Satisfaction Questionnaire (RetTSQ). Int. Congr. Ser. 2005, 1282, 342–346. [Google Scholar] [CrossRef]
- Anderson, R.T.; Skovlund, S.E.; Marrero, D.; Levine, D.W.; Meadows, K.; Brod, M.; Balkrishnan, R. Development and validation of the insulin treatment satisfaction questionnaire. Clin. Ther. 2004, 26, 565–578. [Google Scholar] [CrossRef] [PubMed]
- Taylor, T.R. Understanding the choices that patients make. J. Am. Board Fam. Pract. 2000, 13, 124–133. [Google Scholar] [CrossRef]
- Angeles-Han, S.T.; Griffin, K.W.; Harrison, M.J.; Lehman, T.J.; Leong, T.; Robb, R.R.; Shainberg, M.; Ponder, L.; Lenhart, P.; Hutchinson, A.; et al. Development of a vision-related quality of life instrument for children ages 8-18 years for use in juvenile idiopathic arthritis-associated uveitis. Arthritis Care Res. 2011, 63, 1254–1261. [Google Scholar] [CrossRef] [PubMed]
- Wilkinson, C.P.; Ferris, F.L.; Klein, R.E.; Lee, P.P.; Agardh, C.D.; Davis, M.; Dills, D.; Kampik, A.; Pararajasegaram, R.; Verdaguer, J.T. Global Diabetic Retinopathy Project Group: Proposed internacional clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003, 110, 1677–1682. [Google Scholar] [CrossRef] [PubMed]
- Kovac, B.; Vukosavljevic, M.; Djokic Kovac, J.; Resan, M.; Trajkovic, G.; Jankovic, J.; Smiljanic, M.; Grgurevic, A. Validation and cross- cultural adaptation of the National Eye Institute Visual Function Questionnaire (NEI VFQ-25) in Serbian patients. Health Qual. Life Outcomes 2015, 13, 142. [Google Scholar] [CrossRef] [Green Version]
- Karadžić, J.; Stojković, M.; Risimić, D.; Bozic, M.; Slijepcevic, N.; Polovina, S.; Grgurevic, A. Cross-cultural validation of the Retinopathy Treatment Satisfaction Questionnaire status version (RetTSQs) in Serbian community: A cross-sectional study. BMJ Open 2020, 10, e031236. [Google Scholar] [CrossRef] [Green Version]
- Mangione, C.M.; Lee, P.P.; Gutierrez, P.R.; Spritzer, K.; Berry, S.; Hays, R.D. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch. Ophthalmol. 2001, 119, 1050–1058. [Google Scholar] [CrossRef]
- Tsilimbaris, M.K.; Kontadakis, G.A.; Tsika, C.; Papageorgiou, D.; Charoniti, M. Effect of panretinal photocoagulation treatment on vision-related quality of life of patients with proliferative diabetic retinopathy. Retina 2013, 33, 756–761. [Google Scholar] [CrossRef]
- Ramu, J.; Chatziralli, I.; Yang, Y.; Menon, G.; Bailey, C.; Eckstein, M.; Hykin, P.; Sivaprasad, S. Health-related quality of life, visual function and treatment satisfaction following intravitreal dexamethasone implant for diabetic macular edema. Patient Prefer. Adherence 2017, 11, 579–586. [Google Scholar] [CrossRef] [Green Version]
- Lucena, C.R.; Ramos Filho, J.A.; Messias, A.M.; Silva, J.A.; Almeida, F.P.; Scott, I.U.; Ribeiro, J.A.; Jorge, R. Panretinal photocoagulation versus intravitreal injection retreatment pain in high-risk proliferative diabetic retinopathy. Arq. Bras. Oftalmol. 2013, 76, 18–20. [Google Scholar] [CrossRef] [Green Version]
- Bryl, A.; Mrugacz, M.; Falkowski, M.; Zorena, K. The Effect of Hyperlipidemia on the Course of Diabetic Retinopathy—Literature Review. J. Clin. Med. 2022, 11, 2761. [Google Scholar] [CrossRef] [PubMed]
- Saxena, S.; Ruia, S.; Prasad, S.; Jain, A.; Mishra, N.; Natu, S.M.; Meyer, C.H.; Gilhotra, J.S.; Kruzliak, P.; Akduman, L. Increased serum levels of urea and creatinine are surrogate markers for disruption of retinal photoreceptor external limiting membrane and inner segment ellipsoid zone in type 2 Diabetes Mellitus. Retina 2017, 37, 344–349. [Google Scholar] [CrossRef]
- Zhuang, X.; Cao, D.; Yang, D.; Zeng, Y.; Yu, H.; Wang, J.; Kuang, J.; Xie, J.; Zhang, S.; Zhang, L. Association of diabetic retinopathy and diabetic macular oedema with renal function in southern Chinese patients with type 2 diabetes mellitus: A single-centre observational study. BMJ Open 2019, 9, e031194. [Google Scholar] [CrossRef] [Green Version]
- Amoaku, W.M.; Gale, R.P.; Lotery, A.J.; Menon, G.; Sivaprasad, S.; Petrillo, J.; Quinn, J. Treatment Satisfaction and Well-Being in Patients with Myopic Choroidal Neovascularization Treated with Ranibizumab in the REPAIR Study. PLoS ONE 2015, 10, e0128403. [Google Scholar] [CrossRef]
Variables | Sample, n = 95 |
---|---|
Age (years), mean ± SD | 57.4 ± 13.2 |
Gender, Male, number (%) | 70 (73.7) |
Marital status, number (%) | |
Married | 61 (65) |
Other | 34 (35) |
Educational status, number (%) | |
Elementary school (1–8 years) | 17 (17.9) |
Secondary school | 63 (66.3) |
Higher school | 7 (7.4) |
University degree | 8 (8.4) |
Working status, number (%) | |
Working | 34 (35.8) |
Not working | 16 (16.8) |
Pensioner | 45 (47.4) |
Smoking status, number (%) | |
Yes | 18 (18.9) |
No | 53 (55.8) |
Former smoker | 24 (25.3) |
Physical activity (more than 30 min per day), number (%) | |
Yes | 53 (55.8) |
No | 42 (44.2) |
Visual acuity (Snellen), mean ± SD | |
Better eye | 0.62 ± 0.31 |
Worse eye | 0.43 ± 0.36 |
Scale | Before (Mean ± SD) | After (Mean ± SD) | p-Value |
---|---|---|---|
General health | 36.1 ± 26.5 | 37.1 ± 25.8 | 0.635 |
General vision | 54.3 ± 19.5 | 45.9 ± 25.3 | <0.001 |
Ocular pain | 84.0 ± 18.2 | 82.2 ± 17.8 | 0.258 |
Near activities | 63.2 ± 24.7 | 63.3 ± 23.3 | 0.929 |
Distance activities | 72.9 ± 23.5 | 72.9 ± 25.3 | 0.979 |
Social functioning | 84.3 ± 21.4 | 83.7 ± 23.0 | 0.678 |
Mental health | 53.1 ± 28.3 | 52.0 ± 28.0 | 0.531 |
Role difficulties | 64.6 ± 31.1 | 61.7 ± 31.3 | 0.085 |
Dependency | 77.8 ± 27.4 | 73.8 ± 30.0 | 0.037 |
Driving | 76.5 ± 25.0 | 75.2 ± 20.2 | 0.290 |
Colour vision | 88.0 ± 21.7 | 86.1 ± 21.4 | 0.239 |
Peripheral vision | 74.2 ± 26.7 | 71.6 ± 27.0 | 0.198 |
Composite score | 65.4 ± 17.4 | 63.3 ± 19.5 | 0.045 |
RetTSQ Subscales | Pretreatment Score | Posttreatment Score | Mean | SD | p-Value |
---|---|---|---|---|---|
Overall satisfaction with current treatment | 5.02 | 4.54 | −0.48 | 2.10 | 0.027 |
How well the treatment works | 4.79 | 4.49 | −0.30 | 1.74 | 0.103 |
Side effects; | 4.45 | 4.57 | 0.12 | 2.19 | 0.608 |
Discomfort/pain | 3.46 | 4.39 | 0.93 | 2.33 | <0.001 |
Unpleasantness of treatment | 3.58 | 4.29 | 0.71 | 2.47 | 0.006 |
Ease/difficulty of the treatment | 4.06 | 4.50 | 0.44 | 2.28 | 0.062 |
Apprehension about the treatment | 3.79 | 3.34 | −0.45 | 2.64 | 0.099 |
Patient influence on the treatment | 4.91 | 4.34 | −0.57 | 2.28 | 0.015 |
Safety of the treatment | 5.34 | 5.35 | 0.01 | 1.31 | 0.938 |
Time-taken | 3.96 | 4.06 | 0.11 | 2.28 | 0.654 |
Received information about treatment | 5.48 | 4.88 | −0.60 | 1.64 | 0.001 |
Encouraging others with diabetic eye problems | 5.81 | 5.78 | −0.03 | 0.89 | 0.731 |
Continuity of treatment | 5.64 | 5.49 | −0.15 | 1.30 | 0.271 |
Factors Predicting Change in NEI VFQ-25 | Multivariate Logistic Regression | ||
---|---|---|---|
B | OR (95% CI) | p-Values | |
Mean number of laser spots | −0.003 | 0.997 (0.996–0.999) | 0.002 |
Nephropathy (Yes/No) | 1.072 | 2.922 (0.906–9.425) | 0.073 |
Smoking (Yes/No) | −0.336 | 0.714 (0.272–1.876) | 0.495 |
Hyperlipidaemia (Yes/No) | 0.384 | 1.468 (0.545–3.953) | 0.447 |
Polineuropathy (Yes/No) | 0.780 | 2.181 (0.788–6.039) | 0.133 |
Factors Predicting Change in RetTSQ | Multivariate Logistic Regression | ||
---|---|---|---|
B | OR (95% CI) | p-Values | |
Physical activity (Yes/No) | −0.552 | 0.576 (0.241–1.378) | 0.215 |
Hypertension (Yes/No) | −1.109 | 0.330 (0.091–1.190) | 0.090 |
hyperlipidaemia (Yes/No) | 1.044 | 2.840 (1.168–6.907) | 0.021 |
Presence of DMO on better eye (Yes/No) | −0.655 | 0.519 (0.216–1.251) | 0.144 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Vasilijević, J.B.; Kovačević, I.M.; Bukumirić, Z.M.; Marić, G.D.; Slijepčević, N.A.; Pekmezović, T.D. Vision-Related Quality of Life and Treatment Satisfaction Following Panretinal Photocoagulation in Diabetic Retinopathy—A Panel Study. Medicina 2022, 58, 1741. https://doi.org/10.3390/medicina58121741
Vasilijević JB, Kovačević IM, Bukumirić ZM, Marić GD, Slijepčević NA, Pekmezović TD. Vision-Related Quality of Life and Treatment Satisfaction Following Panretinal Photocoagulation in Diabetic Retinopathy—A Panel Study. Medicina. 2022; 58(12):1741. https://doi.org/10.3390/medicina58121741
Chicago/Turabian StyleVasilijević, Jelena B., Igor M. Kovačević, Zoran M. Bukumirić, Gorica D. Marić, Nikola A. Slijepčević, and Tatjana D. Pekmezović. 2022. "Vision-Related Quality of Life and Treatment Satisfaction Following Panretinal Photocoagulation in Diabetic Retinopathy—A Panel Study" Medicina 58, no. 12: 1741. https://doi.org/10.3390/medicina58121741